CONMED CORPORATION Deferred Tax Expense from Stock Options Exercised
CONMED CORPORATION (CNMD) reported Deferred Tax Expense from Stock Options Exercised of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2018-02-26
- CONMED CORPORATION deferred tax expense from stock options exercised for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CONMED CORPORATION deferred tax expense from stock options exercised for fiscal 2016 was $203.00K, a 94.88% decline from fiscal 2015.
- CONMED CORPORATION deferred tax expense from stock options exercised for fiscal 2015 was $3.96M, a 515.06% increase from fiscal 2014.
- CONMED CORPORATION deferred tax expense from stock options exercised for fiscal 2014 was $644.00K, a 41.29% decline from fiscal 2013.
| Period end | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 |
| 2016-12-31 | $203.00K 10-K · filed 2018-02-26 |
| 2015-12-31 | $3.96M 10-K · filed 2018-02-26 |
| 2014-12-31 | $644.00K 10-K · filed 2017-02-27 |
| 2013-12-31 | $1.10M 10-K · filed 2016-02-23 |
| 2012-12-31 | $1.05M 10-K · filed 2015-02-23 |
| 2011-12-31 | $1.20M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |